Page 1 | Search Results | Blood | American Society of Hematology

1-10 of 10

Sort by

Sort Order Select

Journal Articles

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Kimberly S Esham, MD, Angie Mae Rodday, PhD, Nicole Savidge, BA, Daqin Mao, PhD, Ruth Ann Weidner, MBA, MRP, Susan K Parsons, MD MRP

Blood (2018) 132 (Supplement 1): 3577.

https://doi.org/10.1182/blood-2018-99-111717

Published: 2018

Journal Articles

Health Related Stigma and Quality of Life in Adults with Sickle Cell Disease in Jamaica

Dominique Bulgin, BSN, RN, Paula Tanabe, PhD MSN, MPH, RN, FAEN, FAAN, Asnani Monika, DM, PhD, Christian Douglas, DrPH

Blood (2018) 132 (Supplement 1): 2285.

https://doi.org/10.1182/blood-2018-99-113263

Published: 2018

Journal Articles

Assessment of Health-Related Quality of Life in Adults Hospitalized with Sickle Cell Disease Vaso-Occlusive Crisis

Kimberly S Esham, MD, Angie Mae Rodday, PhD MS, Ruth Ann Weidner, MBA, MRP, Rachel J. Buchsbaum, MD, Hedy P Smith, MD PhD, Susan K Parsons, MD MRP

Blood (2017) 130 (Supplement 1): 2138.

https://doi.org/10.1182/blood.V130.Suppl_1.2138.2138

Published: 2017

Journal Articles

Health-Related Quality of Life (HRQL) Among Hospitalized Adults with Sickle Cell Disease (SCD): Incorporating Patient-Reported Outcome (PRO) Measures in Clinical Care

Kimberly S Esham, MD, Angie Mae Rodday, PhD MS, Ruth Ann Weidner, MBA, MRP, Rachel J. Buchsbaum, MD, Hedy P Smith, MD PhD, Susan K Parsons, MDMRP

Blood (2016) 128 (22): 5962.

https://doi.org/10.1182/blood.V128.22.5962.5962

Published: 2016

Journal Articles

Use of the Functional Assessment of Cancer Therapy-Anemia (FACT-An) Instrument in Persons with MPN-Associated Myelofibrosis and Anemia

Stacie Hudgens, MS, Tom Tencer, Robert Peter Peter Gale, MD, PhD, DSc, Zeba M. Khan, PhD

Blood (2012) 120 (21): 4706.

https://doi.org/10.1182/blood.V120.21.4706.4706

Published: 2012

Journal Articles

Associations Between Improvements in Myelofibrosis (MF) Symptoms and Quality of Life Measures with Splenomegaly Reduction in COMFORT-I: A Randomized, Double-Blind, Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib Versus Placebo in Patients with MF,

Ruben A. Mesa, MD, Jason Gotlib, MD, MS, Vikas Gupta, MD, FRCP, FRCPath, John F. DiPersio, MD, PhD, John Catalano, MD, Michael W. Deininger, Alan Shields, PhD, Carole B. Miller, MD, Richard T. Silver, MD, Moshe Talpaz, MD, Elliott F. Winton, MD, Jimmie H. Harvey, Jr., MD, Thomas Hare, PhD, Sue Erickson-Viitanen, PhD, William Sun, PhD, Victor A. Sandor, MD, CM, Richard S. Levy, MD, Hagop M. Kantarjian, Srdan Verstovsek, MD, PhD

Blood (2011) 118 (21): 3842.

https://doi.org/10.1182/blood.V118.21.3842.3842

Published: 2011

Journal Articles

Clinical Burden and Progression of Myelofibrosis in a Controlled Study Population of Placebo-Treated Patients (COMFORT-I)

Blood (2011) 118 (21): 5146.

https://doi.org/10.1182/blood.V118.21.5146.5146

Published: 2011

Journal Articles

Development of the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM) Scale and Validation in the Eastern Cooperative Oncology Group Trial E1A05,

Matthias Weiss, MD, PhD, Susanna Jacobus, MS, Lynne I Wagner, PhD, David Cella, PhD, Michael S Katz, BS., MBA, Vincent Rajkumar, MD, Rafael Fonseca, MD

Blood (2011) 118 (21): 4184.

https://doi.org/10.1182/blood.V118.21.4184.4184

Published: 2011

Journal Articles

Comprehensive Quality Management of Multiple Electrode Platelet Aggregometry.

Michael Spannagl, MD, Andrea Dick, Andreas Calatzis

Blood (2009) 114 (22): 4463.

https://doi.org/10.1182/blood.V114.22.4463.4463

Published: 2009

Journal Articles

Inter-Laboratory Variation and the Effect of the Type of Fluorimeter on the Results of the Technothrombin® Thrombin Generation Assay.

Piet Meijer, PhD, Cornelis Kluft, PhD

Blood (2006) 108 (11): 3999.

https://doi.org/10.1182/blood.V108.11.3999.3999

Published: 2006

NARROW

Defining Sickle Cell Disease Severity Among Adults Hospitalized with Vaso-Occlusive Crisis

Health Related Stigma and Quality of Life in Adults with Sickle Cell Disease in Jamaica

Assessment of Health-Related Quality of Life in Adults Hospitalized with Sickle Cell Disease Vaso-Occlusive Crisis

Health-Related Quality of Life (HRQL) Among Hospitalized Adults with Sickle Cell Disease (SCD): Incorporating Patient-Reported Outcome (PRO) Measures in Clinical Care

Use of the Functional Assessment of Cancer Therapy-Anemia (FACT-An) Instrument in Persons with MPN-Associated Myelofibrosis and Anemia

Associations Between Improvements in Myelofibrosis (MF) Symptoms and Quality of Life Measures with Splenomegaly Reduction in COMFORT-I: A Randomized, Double-Blind, Phase III Trial of the JAK1 and JAK2 Inhibitor Ruxolitinib Versus Placebo in Patients with MF,

Clinical Burden and Progression of Myelofibrosis in a Controlled Study Population of Placebo-Treated Patients (COMFORT-I)

Development of the Functional Assessment of Cancer Therapy-Multiple Myeloma (FACT-MM) Scale and Validation in the Eastern Cooperative Oncology Group Trial E1A05,

Comprehensive Quality Management of Multiple Electrode Platelet Aggregometry.

Inter-Laboratory Variation and the Effect of the Type of Fluorimeter on the Results of the Technothrombin® Thrombin Generation Assay.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only